After reading these articles, you should be able to…

There are plenty of ways that we use technology in psychiatric practice these days—including e-prescribing, electronic health records, referring patients to websites for psychoeducation, etc. But when was the last time you referred a patient to their computer for psychotherapy? Well, it may be time to consider it.

Get advice on how you can become a top-performing clinician, including how to put processes in place to consistently get feedback from your patients, in an interview with Scott D. Miller, PhD, found and director of the International Center for Clinical Excellence.

Repetitive transcranial magnetic stimulation (rTMS) is approved by the US Food and Drug Administration (FDA) for treatment resistant depression (TRD), and presumably works by modulating brain circuitry. A new meta-analysis focuses specifically on using rTMS as augmentation to antidepressants in patients with TRD.

Lisdexamfetamine (Vyvanse), a stimulant approved for treating kids and adults with ADHD, is the first drug approved by the US Food and Drug Administration (FDA) for treating adults with binge-eating disorder (BED).

After reading these articles, you should be able to…

There’s a new medication on the market for the treatment of dementia—the first to come along in several years.

If you’re like most psychiatrists, you get your fair share of older folks who come into the office complaining of difficulties with sleep or with significant symptoms of anxiety.

Get advice on how to assess and work with patients with cognitive impairment and dementia, in an interview with Marc Agronin, MD, Geriatric Psychiatrist and Vice President of Behavioral Health and Clinical Research at Miami Jewish Health Systems.

Many medications have anticholinergic side effects, which can be particularly troublesome for the elderly.